The US Bankruptcy Court gave an order approving the sale of the certain assets of Sienna Biopharmaceuticals, Inc. on February 5, 2021. The debtor has been authorized to sell its certain assets to Avro Life Sciences, Inc. for a purchase price of $0.1 million in cash pursuant to the asset purchase agreement dated January 29, 2021. The transaction is expected to close on a date mutually agreed upon by the parties. The buyer is represented by Mike Gustafson of Faegre Drinker Biddle & Reath LLP as its legal advisor.